bladder cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
bladder cancer
Jul 26, 2024, 11:01 |
Blog
Articles on GU Cancers From the 2024 ASCO Educational Book suggested by Paulo Bergerot
Paulo Bergerot, Medical Oncologist at Grupo Oncoclínicas, shared on X: . "Our very long…
Jul 26, 2024, 00:49 |
Blog
SIU-Urology - Participate in the 6th B2B GU Cancers Triad Meeting
SIU-Urology shared on X: "Don’t miss out on the opportunity to participate in the 6th B2B…
Jul 25, 2024, 02:35 |
Insight
Guru P. Sonpavde: Pleased to review emerging vaccine immunotherapy approaches to treat bladder cancer
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X: "Pleased to…
Jul 22, 2024, 23:12 |
Blog
Molly Fuchs: TUM for cloacal repair does not impair bladder function performed in the correct patient
Molly Fuchs, Pediatric Urologist at Nationwide Children's Hospital, shared a post on X: ''Hot off the…
Jul 22, 2024, 07:49 |
Blog
Tian Zhang: Best of ASCO Dallas 2024
Best of ASCO, an Official Annual Meeting Review of the American Society of Clinical Oncology…
Jul 19, 2024, 14:41 |
Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jul 11, 2024, 06:37 |
Insight
Results of the Complete Review on Targeted Therapies for Advanced Urothelial Carcinoma
María Natalia Gandur Quiroga shared on X: " Results and Main Messages of the Complete…
Jul 11, 2024, 06:26 |
Insight
The Role of Antibody-Drug conjugates (ADCs) in Bladder Cancer
Bladder Cancer Advocacy Network shared on X: "Get practical guidance on using antibody–drug conjugates in…
Jul 11, 2024, 03:10 |
Blog
Neeraj Agarwal: A terrific whirlwind tour of bladder cancer treatment landscape by Shilpa Gupta
Neeraj Agarwal shared a post on X: “A terrific whirlwind tour of bladder cancer treatment…
Jul 8, 2024, 14:04 |
Blog
Morgan Roberts: Finished my first week as a new PI
Peter Black, Urologic Oncologist at Vancouver Prostate Centre, shared a post by Morgan Roberts, Senior Research Scientist…
Jul 7, 2024, 15:43 |
Blog
Petros Grivas: Phenomenal tour de force on bladder cancer by Shilpa Gupta
Petros Grivas shared on X: "Phenomenal tour de force presentation by the master Shilpa Gupta covering…
Jul 6, 2024, 13:40 |
Blog
Enrique Grande: Resistance to new drugs in bladder cancer
Enrique Grande shared a post on X: “Very happy to share our contribution to ASCO…
Jul 5, 2024, 01:21 |
Insight
Liang Cheng: Our paper has been selected as the Cover Story in a recent issue by Wiley Oncology and Hematology
Liang Cheng, Director of Anatomic Pathology and Molecular Pathology at Warren Alpert Medical School of…
Jul 4, 2024, 12:07 |
Blog
Jordyn Silverstein: Bladder cancer illness script time
Jordyn Silverstein, Hematology/Oncology Fellow at UCLA, made the following post on X: "Illness script time!…
Jul 4, 2024, 03:22 |
Blog
Updates from Upstate NY Cancer Symposium by Oncology Brothers
Oncology Brothers shared on X: "Updates from Upstate NY Cancer Symposium: India is now T20 Champions! Back…
Jul 2, 2024, 13:03 |
Insight
Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting
Petros Grivas shared a post by Maciej M Mrugala, Director-Neuro-Oncology Fellowship Program at Mayo Clinic on…
Jul 2, 2024, 11:31 |
Blog
Challenges in non-muscle invasive bladder cancer by Ashish Kamat
Enrique Grande shared on X: . "Brilliant talk about challenges in…
Jul 2, 2024, 11:12 |
Blog
Enrique Grande: Fabulous and inspiring view of the short term future of advanced bladder cancer
Enrique Grande shared a post on X: …
Jun 30, 2024, 16:16 |
Blog
Gianluca Giannarini: Great joint ESUI - EAU Section Urological Imaging session
Gianluca Giannarini, Associate Editor of European Urology, Full Board Member of the EAU Guidelines Office, shared…
Jun 30, 2024, 14:19 |
Insight
Reprogramming Tumor-Associated Macrophages with Glutamine Antagonist JHU083
Maria Babak shared a post by The Babak Lab on LinkedIn: "Absolutely thrilled to see…
Jun 30, 2024, 13:21 |
Blog
Khurshid Guru’s book titled “A Patient’s Guide to Bladder Cancer”
Roswell Park Comprehensive Cancer Center shared a post on LinkedIn: “New Episode Alert! Dr. Khurshid…
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 25, 2024, 03:54 |
Insight
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System
Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…
Jun 24, 2024, 02:32 |
Insight
Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X: …
Jun 23, 2024, 17:14 |
Blog
Sarah Psutka: A masterclass across the spectrum of bladder cancer at UROonco24
Sarah Psutka, Urologic Oncologist, Associate Professor at University of Washington School of Medicine, shared on…
Jun 23, 2024, 04:34 |
Insight
Ashish Kamat: IBCG scoring system and substratification model for IR NMIBC
Ashish Kamat, Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD…
Jun 22, 2024, 02:24 |
Insight
Guru Sonpavde: ctDNA for Evaluating Minimal Residual Disease in Bladder Cancer
Guru Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, posted on…
Jun 21, 2024, 05:08 |
Insight
Enrique Grande: A Molecular-Directed Strategy with TP53 Mutation in small cell bladder cancer
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
Jun 19, 2024, 07:50 |
Blog
Roger Li: The final results of the CORE001 trial are out now in Nature Medicine
Patrick Hwu shared a post by Roger Li, Urologic oncologist at Moffitt Cancer Center, on…
Jun 18, 2024, 17:53 |
Blog
Sabine D. Brookman-May: Older patients with NMIBC show more aggressive tumors
Sabine D. Brookman-May, Professor of Urology at Ludwig-Maximilians University, shared a post by Niyati Lobo, Consultant…
Jun 5, 2024, 12:44 |
Blog
Tom Powles: Perhaps the most important long-term bladder cancer data at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: ''Perhaps the most important long-term…
Jun 4, 2024, 16:37 |
Societies
Wafik S. El-Deiry: Great to run into my colleague David De Graff
Wafik S. El-Deiry, shared a post on X: “Great to run into my colleague, David De…
Jun 4, 2024, 10:19 |
Insight
Earle Burgess: The big news in advanced urothelial (bladder) cancer at ASCO24 isn’t at ASCO24
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared a post on LinkedIn: “The…
Jun 4, 2024, 09:39 |
Societies
ASCO24 Day 4 Highlights by The Oncology Brothers
The Oncology Brothers shared on X: "ASCO24 Day 4 Highlights: 1. ICTAN: Adjuvant anti-EGFR duration…
Jun 1, 2024, 10:00 |
Insight
Tom Powles: TROPICS-4 in heavily pretreated bladder cancer missed OS
Tom Powles, Director of Barts Cancer Center, shared on X: “TROPICS-4 (sacituzumab, govitecan versus chemo) in…
May 31, 2024, 11:54 |
Blog
Tian Zhang: My top themes of ASCO24
Tian Zhang shared a post on X: "My top themes of ASCO24 for kidney cancer, prostate…
May 29, 2024, 09:04 |
Societies
Shilpa Gupta: Glad to present our work on physician-reported 1L treatment patterns in 5 European countries
Enrique Grande, recently shared a post by Shilpa Gupta on X, adding: "We all always…
May 26, 2024, 11:35 |
Insight
Bladder cancer highlights for ASCO24 by Tom Powles
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: "Bladder cancer highlights for ASCO24. Practice…
May 25, 2024, 15:15 |
Blog
JJ Zhang: Bladder Cancer Advocacy Network's Seattle Walk to End Bladder Cancer was a huge success
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of…
May 23, 2024, 11:34 |
Blog
Petros Grivas: We became 1 family raising awareness for bladder cancer at Bladder Cancer Advocacy Network
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…
May 22, 2024, 00:45 |
Blog
Aliya Mahmood Khan: I'm thrilled to share that we will be presenting at the AACR Special Conference on Bladder Cancer
Aliya Mahmood Khan, Resident Physician in Broward Health, shared on X: "I'm thrilled to share…
May 21, 2024, 05:34 |
Insight
Laura Bukavina: Gut microbiome may influence chemo response in bladder cancer patients
Nazli Dizman, A Hematology/Oncology Fellow at MD Anderson Cancer Center, shared a post by Laura…
May 20, 2024, 14:40 |
Blog
Dimitra Bakaloudi: Great time at the bladder cancer walk in Seattle
Dimitra Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X/Twitter: "We had a…
May 18, 2024, 10:52 |
Insight
Laura Bukavina: Gut microbiome may influence chemo response in bladder cancer patients
Amanda Nizam, GU Medical Oncologist at Cleveland Clinic, shared a post by Laura Bukavina, Urologic…
May 16, 2024, 09:08 |
Blog
Bogdana Schmidt: I am lucky to have an amazing team!
Bogdana Schmidt, urologic surgeon specializing in urologic oncology at the University of Utah, shared a post…
May 14, 2024, 09:21 |
Drugs
Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer
Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…
May 13, 2024, 08:04 |
Insight
Petros Grivas: We are getting ready for annual bladder cancer walk in Seattle Lake Sammamish
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…
May 12, 2024, 07:49 |
Blog
Dan Theodorescu: I’m thrilled to be a co-chair for the AACR Special Conference in Cancer Research
Dan Theodorescu, Director of Cedars-Sinai Cancer Center, made the following post on X: "I’m thrilled…
May 12, 2024, 01:23 |
Societies
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Cedars-Sinai Co-Chairs Special Conference in Cancer Research Covering Transformational Developments in Treatment In partnership with…
May 12, 2024, 00:24 |
Insight
Karima Oualla: IBCG- AUA Bladder Cancer Forum
Karima Oualla, Professor of Medical Oncology at Hassan II University Hospital, shared a post on LinkedIn:…
May 11, 2024, 12:27 |
Blog
Erman Akkus on GLP1 Agonists in T2DM and Risk of Urological Cancers
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “GLP1 Agonists in…
May 7, 2024, 10:25 |
Career
Tom Powles has been named in TIME100 Health - Barts and The London School of Medicine and Dentistry
Toni Choueiri shared a post by Barts and The London School of Medicine and Dentistry…
May 6, 2024, 14:55 |
Blog
Petros Grivas: Great chat on Bladder Cancer
Petros Grivas, GU oncologist at Fred Hutchinson Cancer Center and Director of the University of Washington…
May 3, 2024, 00:05 |
Blog
Jeremy Teoh: ERBT could reduce the 1-year recurrence rate in NMIBC
Jeremy Teoh, Assistant Dean (External Affairs) & Associate Professor at CUHK Medicine, made the following…
May 1, 2024, 08:57 |
Blog
Shilpa Gupta: Looking forward to debate session in bladder cancer
Shilpa Gupta, Director GU Oncology at Cleveland Clinic MD, shared a post by Ashish M.…
Apr 28, 2024, 12:18 |
Blog
Laura Bukavina: Microbiome analysis of WGS of urine samples in bladder cancer is now interactive
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X/Twitter:…
Apr 28, 2024, 10:46 |
Insight
Sumanta Pal: Kicking off our Southern California Regional Collaborative journal club
Sumanta Pal, Head of the Kidney and Bladder Cancer Disease at City of Hope Medical…
Apr 26, 2024, 11:03 |
Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 24, 2024, 22:44 |
Blog
Amol Akhade: Can u pronounce name of this latest approved drug by US FDA correctly?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared a post on X: "Can u…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 14, 2024, 06:07 |
Insight
Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer
Thomas Flaig, Vice Chancellor for Research at University of Colorado Denver, shared on X/Twitter: "Honored…
Apr 1, 2024, 15:31 |
Blog
Tom Powles: Easter paper of the month with Matt Galsky
Tom Powles, Director of Barts Cancer Center, shared a post on X: "Easter paper of…
Apr 1, 2024, 13:09 |
Insight
Yüksel Ürün: This research suggests ctDNA could revolutionize pre-surgical decision-making and treatment strategies, ensuring more personalized care
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter: "Circulating tumor DNA…
Mar 30, 2024, 09:30 |
Blog
The updated Algorithm for Bladder Cancer - Oncology Brothers
Oncology Brothers shared on X/Twitter: "This is the updated Algorithm for Bladder Cancer. Nivo/Gem/Cis was not…
Mar 29, 2024, 19:30 |
Insight
Maria Natalia Gandur Quiroga: New Insights on Bladder Cancer Invasion
Maria Natalia Gandur Quiroga shared on X/Twitter: "New Insights on Bladder Cancer Invasion. Unraveling a…
Mar 22, 2024, 06:20 |
Societies
The 3rd World Bladder Cancer Patient Forum was a milestone event for our international community - World Bladder Cancer Patient Coalition
World Bladder Cancer Patient Coalition, posted on LinkedIn: "The 3rd World Bladder Cancer Patient Forum…
Mar 17, 2024, 19:51 |
Insight
Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care
Tom Powles, Director of Barts Cancer Center, shared a post on X: "New ESMO's guidelines for…
Mar 15, 2024, 15:26 |
Insight
Enfortumab+pembrolizumab combination as the 1st line treatment of choice for advanced urothelial cancer - summary by Piotr J. Wysocki
Piotr J. Wysocki, Professor of Medicine, Head of Department of Oncology at Jagiellonian University Hospital,…
Mar 9, 2024, 12:26 |
Blog
Susanna F. Greer: Bladder cancer meets its match
Susanna F. Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the…
Feb 25, 2024, 16:11 |
Insight
Aruni Ghose: Delighted to see our prospective blinded validation trial on the URO17 urinary bladder cancer biomarker published in BMC Urology by Springer Nature Group
Aruni Ghose, Focused Topic Network Member at European Cancer Organisation, shared a post on LinkedIn: ''Delighted…
Feb 23, 2024, 17:59 |
Blog
Wafik El-Deiry: Rhode Island has one of the highest rates of bladder cancer in the US
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Feb 21, 2024, 18:44 |
Blog
Liang Cheng: NEWEST State-of-the Art -Review on Bladder Cancer Diagnosis and Treatment
Liang Cheng, Professor and Vice Chair for Translational Research at Warren Alpert Medical School of Brown…
Feb 21, 2024, 18:28 |
Insight
Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR
Sabine Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X/Twitter: "Finally…
Feb 19, 2024, 17:05 |
Drugs
Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on LinkedIn: "Today, the FDA…
Feb 1, 2024, 04:54 |
Blog
Chris Boshoff: The European Medicines Agency (EMA) has accepted our application in collaboration with Astellas Pharma US and Merck for a combination therapy for advanced Urothelial Cancer
Jan 31, 2024, 17:49 |
Insight
Earle Burgess: Initial results from a small pilot study in late mCRPC where there are limited to no effective treatment options available
Earle Burgess, Genitourinary Oncologist at Atrium Health Levine Cancer, shared on LinkedIn: "Enfortumab vedotin is…
Jan 30, 2024, 15:45 |
Societies
Chiara Mercinelli: An honor to present Nure Combo trial at ASCO GU24
Chiara Mercinelli, Fellow Research Oncology Resident IRCCS San Raffaele, posted on X/Twitter: "It has been…
Jan 26, 2024, 17:52 |
Blog
Chiara Mercinelli: Thrilled to present our recent work on muscle-invasive bladder cancer
Chiara Mercinelli, a Research Student on Genitourinary Oncology at Vita-Salute San Raffaele University, recently shared…
Jan 19, 2024, 08:43 |
Drugs
María Natalia Gandur Quiroga: A significant advancement in bladder cancer treatment
María Natalia Gandur Quiroga shared on X/Twitter: "The article 'FGFR inhibition augments anti–PD-1 efficacy in…
Dec 19, 2023, 09:10 |
Insight
Tom Powles: EV/pembro will transform the lives of many patients with this difficult disease
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "A big day…
Dec 8, 2023, 17:46 |
Drugs
Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?
Earle Burgess, Chief of the Genitourinary Oncology Section at Atrium Health, Levine Cancer Institute, shared…
Dec 5, 2023, 19:00 |
Blog
Sumanta Pal: To all my friends in academia, industry, community practice and beyond
Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared on…
Dec 4, 2023, 16:05 |
Blog
Abhishek Shankar: My take away from Jammu CRABECON
Abhishek Shankar, Associate Professor in the Department of Radiation Oncology at All India Institute of…
Dec 4, 2023, 15:11 |
Blog
Tom Powles: This is the next chapter IMO
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Treatment for muscle…
Nov 23, 2023, 16:04 |
Blog
Ashish M. Kamat: Our collaborative review on Lymph Node Dissection in GU cancers
Ashish M. Kamat, Professor of Urologic Oncology (Surgery) and Cancer Research at M.D. Anderson Cancer…
Nov 21, 2023, 13:57 |
Blog
Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 15, 2023, 17:32 |
Insight
Omar Alhalabi: Have you treated bladder cancer with a component of "neuroendocrine" or "small cell" carcinoma?
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, posted on Twitter. "Have you…
Nov 14, 2023, 03:56 |
Insight
Guru P. Sonpavde: Honored to write this commentary...
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "Nivolumab…
Nov 7, 2023, 03:03 |
Dialogues
5min OncoDaily Updates with Chandler Park: Vadim Koshkin discusses an innovative positive study of re-challenging patients with immunotherapy for metastatic bladder cancer patient
Oct 31, 2023, 04:25 |
Dialogues
5min OncoDaily Updates with Chandler Park: Dr. Yüksel Urun on practice changing CheckMate 901 study for bladder cancer patients
[embed]https://www.youtube.com/watch?v=5qJ8T2SFHOA[/embed]
Oct 24, 2023, 19:58 |
Blog
Elizabeth Plimack: Kudos to Amanda Nizam for winning Best ESMO2023 Poster in Urothelial
Elizabeth Plimack, Deputy Director Fox Chase Cancer Center, made the following post on Twitter: "Kudos…
Oct 23, 2023, 15:26 |
Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Oct 23, 2023, 15:24 |
Insight
Why radiotherapy with concomitant chemotherapy is an excellent option for bladder preservation in bladder cancer patients
Pierre Blanchard, Full Professor of Radiation Oncology at Gustave Roussy Cancer Center, posted on his…
Oct 8, 2023, 17:16 |
Blog
Sumanta K. Pal: I'm hugely indebted to Matt Galsky, not just for the chance to be a part of this Nature Medicine masterpiece he drove, but to see the joy of my pts doing well years out from chemo/IO without cystectomy.
Oct 2, 2023, 18:39 |
Blog
Todd Waldman: We have a post-doctoral position available in my lab to study the function of the STAG2 tumor suppressor gene in the pathogenesis of human cancer.
Quoting Todd Waldman, Professor of Oncology, Molecular Biology, and Genetics and Director of the MD/PhD…
Aug 9, 2023, 06:42 |
Blog
Great collaboration between Global Society of Rare GU tumors and International Bladder Cancer Group - Karima Oualla
Honored to be part of the fantastic Bladder Cancer Advocacy Network Think Tank, that took…
Jul 31, 2023, 15:46 |
Blog
En bloc resection of bladder tumours has been proposed as an alternative technique - Edward Bruce-White
Standard bladder-cancer resection is conventionally performed by resecting the tumour piecemeal. En bloc resection of…
Jul 22, 2023, 19:34 |
Blog
CRI congratulates SURGE Therapeutics on their completion of a $32 million Series B financing - Cancer Research Institute
CRI congratulates SURGE Therapeutics, led by former CRI CLIP Award Grantee Michael Goldberg, Ph.D, on their completion…
Jun 26, 2023, 19:13 |
Blog
Patients with loss of Y chromosome (LOY) had poorer prognosis when their bladders were removed, but somewhat paradoxically, better overall survival rates when they received immune checkpoint inhibitors
1
2
All:
102
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube